Oxford Biomedica has brought its Durham GMP manufacturing capacity online. The first regulated run has been completed after a six-month delay, adding US viral vector manufacturing capacity to OXB’s global CDMO network.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.